SEP 12, 2026 · JOURNAL ARTICLE
Development and preclinical evaluation of a decoy DLL4-encoding oncolytic HSV-1 for high-grade glioma
Oncogene
Preclinical and clinical investigation of oncolytic HSV-1 (oHSV) treatment for cancer has indicated increased Notch signaling in tumors after treatment. Since Notch activation ofte